Loading
Yanuki
KEYWORD TOPIC
Pfizer Acquires Metsera for $10 Billion Amidst Bidding War | Novo Nordisk Ups Bid for Metsera Amidst Pfizer Competition | Novo Nordisk and Pfizer Engage in Bidding War Over Metsera | Pfizer Expands GLP-1 Pipeline with Metsera Acquisition | Market Recap: Dow, S&P 500, and Nasdaq Pull Back as Gold Shines; Pfizer Acquires Metsera | Pfizer Acquires Metsera for $10 Billion Amidst Bidding War | Novo Nordisk Ups Bid for Metsera Amidst Pfizer Competition | Novo Nordisk and Pfizer Engage in Bidding War Over Metsera | Pfizer Expands GLP-1 Pipeline with Metsera Acquisition | Market Recap: Dow, S&P 500, and Nasdaq Pull Back as Gold Shines; Pfizer Acquires Metsera

Business / Pharmaceuticals

Pfizer Acquires Metsera for $10 Billion Amidst Bidding War

Pfizer has successfully acquired Metsera, an obesity drug developer, for $10 billion, concluding a competitive bidding war with Novo Nordisk. This acquisition marks Pfizer's strategic entry into the rapidly expanding weight loss market.

Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle
Pfizer Acquires Metsera for $10 Billion Amidst Bidding War Image via CNBC
TOPIC metsera

Health / Pharma

Novo Nordisk Ups Bid for Metsera Amidst Pfizer Competition

The race to dominate the obesity and diabetes drug market is heating up, with Novo Nordisk and Pfizer battling to acquire Metsera. This acquisition would bolster their pipelines with innovative treatments.

Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

Business / Biotech and Pharma

Novo Nordisk and Pfizer Engage in Bidding War Over Metsera

Novo Nordisk and Pfizer are in a bidding war to acquire Metsera, a U.S. biotech firm specializing in obesity drugs. The competition highlights the increasing importance of the weight-loss drug market, projected to reach $150 billion by the...

Novo Nordisk hijacks Pfizer with bid for U.S. biotech Metsera

Finance / Pharma

Pfizer Expands GLP-1 Pipeline with Metsera Acquisition

Pfizer (PFE) is strategically expanding its pipeline in the GLP-1 obesity market through the acquisition of Metsera. This move aims to strengthen Pfizer's position in the rapidly growing weight management sector, projected to reach $150 bil...

Pfizer Just Reminded Investors Why You Should Never Count Its Stock Out

Finance / Stock Market

Market Recap: Dow, S&P 500, and Nasdaq Pull Back as Gold Shines; Pfizer Acquires Metsera

US stocks experienced a slight retreat on Monday, September 22, 2025, as investors awaited key economic data and insights from Federal Reserve officials. Meanwhile, gold reached a new high, and Pfizer announced its acquisition of Metsera.

Stock market today: Dow, S&P 500, Nasdaq pull back from records as gold powers to fresh high